Genelux Corp (GNLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,338 | 397 | 0 | 0 | 0 |
| TOTAL | $12,056 | $1,892 | $0 | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 617 | 644 | N/A | N/A | N/A |
| Other Non-Current Assets | 1,943 | 2,995 | 0 | 0 | 0 |
| TOTAL | $2,560 | $3,639 | $N/A | $N/A | $N/A |
| Total Assets | $14,616 | $5,531 | $0 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,292 | 6,775 | 0 | 0 | 0 |
| Accrued Expenses | 3,018 | 7,847 | 0 | 0 | 0 |
| Other current liabilities | N/A | 169 | 0 | 0 | 0 |
| TOTAL | $10,543 | $31,626 | $0 | $0 | $0 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 170 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 1,382 | 9,688 | 0 | 0 | 0 |
| TOTAL | $1,382 | $9,688 | $N/A | $N/A | $N/A |
| Total Liabilities | $11,925 | $41,314 | $0 | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 24,665 | N/A | N/A | N/A | N/A |
| Common Shares | 25 | 9 | 0 | 0 | 0 |
| Retained earnings | -203,591 | -189,784 | 0 | 0 | 0 |
| Other shareholders' equity | -431 | -431 | 0 | 0 | 0 |
| TOTAL | $2,691 | $-35,783 | $0 | $0 | $0 |
| Total Liabilities And Equity | $14,616 | $5,531 | $0 | $0 | $0 |